Tunlametinib | Interleukin Related interleukin-related.com

Product Name :
Tunlametinib

Search keywords :
MEK2

drugId :
null

Target Vo:
Dual specificity mitogen-activated protein kinase kinase 1

Target Vo Short Name :
MEK1

Moa_Name:
Dual specificity mitogen-activated protein kinase kinase 1 inhibitors

First Approval Country :
Mainland China

First Approval Date Filter:
2024

Origin Company_Name :
KeChow Pharma Inc

Active Company_Name :
KeChow Pharma Inc

Active Indication_Name:
Melanoma

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-Histone H2A.X (Ser139) Antibody
PD-1 Antibody
Phospho-EGFR (Y1068) Antibody (YA204): Phospho-EGFR Antibody (YA204) is a non-conjugated and Rabbit origined monoclonal antibody about 134 kDa, targeting to Phospho-EGFR(Y1068). It can be used for WB,ICC/IF,IP,FC assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts